AMBQ on NYSE
Ambiq Micro, Inc.
Price unavailable
Last updated Oct 16, 2026.
Overview
Compare with LIGHTPATH TECHNOLOGIES INC, Valens Semiconductor or Arteris, Inc., or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
44.3%Gross margin3
-54.5%Operating margin3
-50.3%Net margin3
-4.7%Revenue growth, 20253
-22.4%Return on equity3
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Regions
[Canada] brought in 42% of the revenue Ambiq Micro, Inc. broke down this way in fiscal 2025.
Regions by year
| Regions | 2024 | 2025 |
|---|---|---|
| [Canada] | $54.7M | $30.7M |
| Taiwan | $18.2M | $25.8M |
| Other Countries | $3.1M | $8.7M |
| Singapore | $0 | $7.3M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue36¢$40.4M
- Research and development34¢$38.5M
- Selling, general and admin30¢$33.2M
- Income tax0¢$40.0K
Out of $72.5M in revenue.3 The company lost money this year.
Financial statements
Every line of the income statement in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net sales | $72.5M | $76.1M |
| Cost of sales | $40.4M | $51.8M |
| Gross profit | $32.1M | $24.3M |
| Research and development | $38.5M | $37.2M |
| Selling, general, and administrative | $33.2M | $27.7M |
| Total operating expenses | $71.6M | $64.9M |
| Loss from operations | -$39.5M | -$40.6M |
| Other income, net | $3.1M | $980.0K |
| Loss before provision for income taxes | -$36.4M | -$39.6M |
| Provision for income taxes | $40.0K | $28.0K |
| Net loss | -$36.5M | -$39.7M |
| Deemed dividends | $0 | -$2.7M |
| Net loss attributable to common stockholders | -$36.5M | -$42.4M |
| Net loss per share attributable to common stockholders, basic | -$4.57 | -$113.50 |
| Net loss per share attributable to common stockholders, diluted | -$4.57 | -$113.50 |
| Weighted-average shares used in computing net loss per share attributable to common stockholders, basic | 8.0M shares | 373.4K shares |
| Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted | 8.0M shares | 373.4K shares |
| Currency translation adjustment | $80.0K | $319.0K |
| Comprehensive loss | -$36.4M | -$39.3M |
| Deemed dividends | $0 | -$2.7M |
| Comprehensive loss attributable to common stockholders | -$36.4M | -$42.1M |
Every line of the balance sheet in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $140.3M | $61.0M | |
| Accounts receivable, net | $7.3M | $10.4M | |
| Inventories, net | $16.9M | $15.0M | |
| Prepaid expenses and other current assets | $3.4M | $2.6M | |
| Total current assets | $167.9M | $89.0M | |
| Property, equipment and software, net of accumulated depreciation and amortization of $14,632 and $13,158, respectively | $4.1M | $2.6M | |
| Right-of-use assets, net | $638.0K | $928.0K | |
| Intangible assets, net of accumulated amortization of $10,752 and $5,082, respectively | $11.6M | $11.7M | |
| Other assets | $393.0K | $49.0K | |
| Total assets | $184.7M | $104.3M | |
| Accounts payable | $8.6M | $2.9M | |
| Accrued and other current liabilities | $10.2M | $8.2M | |
| Short-term lease liabilities | $400.0K | $633.0K | |
| Total current liabilities | $19.2M | $11.8M | |
| Long-term lease liabilities | $278.0K | $333.0K | |
| Warrant liabilities | $0 | $112.0K | |
| Other long-term liabilities | $2.8M | $6.3M | |
| Total liabilities | $22.2M | $18.5M | |
| Redeemable convertible preferred stock, $0.000001 par value; 10,000,000 shares authorized; 0 and 341,496,158 shares issued and outstanding at December 31, 2025 and December 31, 2024. | $0 | $378.1M | |
| Common stock, $0.000001 par value; 500,000,000 shares authorized; 18,316,928 shares and 434,720 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | $0 | $0 | |
| Additional paid-in-capital | $519.6M | $28.4M | |
| Accumulated deficit | -$356.7M | -$320.2M | |
| Accumulated other comprehensive loss | -$440.0K | -$520.0K | |
| Total stockholders' equity (deficit) | $162.5M | -$292.4M | -$261.0M |
| Total liabilities, redeemable convertible preferred stock and stockholders' equity (deficit) | $184.7M | $104.3M | |
| Property, equipment and software, net of accumulated depreciation and amortization | $14.6M | $13.2M | |
| Intangible assets, net of accumulated amortization | $10.8M | $5.1M | |
| Common stock, par value | $0.00 | $0.00 | |
| Common stock, shares authorized | 500.0M shares | 500.0M shares | |
| Common stock, shares issued | 18.3M shares | 434.7K shares | |
| Common stock, shares outstanding | 18.3M shares | 434.7K shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net Income (Loss) | -$36.5M | -$39.7M |
| Depreciation and amortization | $7.2M | $6.2M |
| Stock-based compensation | $6.8M | $5.2M |
| Gain on receipt of nonmonetary tangible assets | -$1.6M | -$1.6M |
| Change in right-of-use assets | $698.0K | $987.0K |
| Non-cash issuance of warrants | $0 | $1.9M |
| Change in warrant valuations and cancellations | $60.0K | -$51.0K |
| Inventory valuation adjustment | $199.0K | $428.0K |
| Other | -$110.0K | $0 |
| Accounts receivable | $3.2M | $1.8M |
| Inventories | -$2.1M | $6.0M |
| Prepaid expenses and other assets | -$844.0K | $521.0K |
| Other long-term assets | -$344.0K | $0 |
| Accounts payable | $2.9M | $821.0K |
| Accrued and other current liabilities | $1.0M | -$3.6M |
| Other long-term liabilities | -$317.0K | -$463.0K |
| Net cash used in operating activities | -$19.7M | -$21.4M |
| Purchase of intangible assets | -$6.1M | -$3.1M |
| Purchases of property, equipment and software | -$1.3M | -$658.0K |
| Net cash used in investing activities | -$7.4M | -$3.7M |
| Proceeds from issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions | $102.7M | $0 |
| Payment of deferred offering costs | -$2.8M | $0 |
| Proceeds from issuance of preferred stock, net of issuance costs | $0 | $58.0M |
| Proceeds from exercise of stock options | $839.0K | $854.0K |
| Proceeds from exercise of warrants | $5.7M | $0 |
| Net cash provided by financing activities | $106.4M | $58.8M |
| Effect of exchange rate changes on cash and cash equivalents | $43.0K | -$24.0K |
| Net increase in cash and cash equivalents | $79.3M | $33.7M |
| Intangible assets in accounts payable, accrued and other long-term liabilities | $9.8M | $10.3M |
| Gain on receipt of nonmonetary tangible asset | $1.6M | $1.6M |
| Right-of-use assets obtained in exchange for new operating lease liabilities | $382.0K | $1.2M |
| Non-cash deferred offering costs | -$300.0K | $0 |
| Deemed dividends | $0 | $2.7M |
Recent filings
- Oct 6, 20264
- Oct 6, 20264
- Oct 6, 20264
- Oct 6, 20264
- Oct 5, 2026144
- Oct 2, 2026144
- Oct 2, 2026144
- Oct 2, 2026144
- Oct 2, 2026144
- Sep 17, 20264
- Sep 15, 20264
- Sep 15, 20264
- Sep 15, 20264
- Sep 11, 2026144
- Sep 11, 2026144
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5